Cargando…
Clinical Practice Changes After Post-Market Safety Reports on Desmopressin Orally Disintegrating Tablet in Japan: A Single-Center Retrospective Study
BACKGROUND: Desmopressin orally disintegrating tablet (ODT) was approved in March 2012 in Japan; the post-market safety reports, which warned about adequate initial dose of desmopressin ODT, were published in 2014. However, it is unclear how the warning affected physician and patient behavior. METHO...
Autores principales: | Yasuda, Takuma, Murakami, Takaaki, Yasoda, Akihiro, Sone, Masakatsu, Harada, Norio, Ogura, Masahito, Inagaki, Nobuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935623/ https://www.ncbi.nlm.nih.gov/pubmed/33747323 http://dx.doi.org/10.14740/jocmr4399 |
Ejemplares similares
-
Low-dose Selective Arterial Calcium Stimulation Test for Localizing Insulinoma: A Single-center Experience of Five Consecutive Cases
por: Hatoko, Tomonobu, et al.
Publicado: (2020) -
Year‐long effects of COVID‐19 restrictions on glycemic control and body composition in patients with glucose intolerance in Japan: A single‐center retrospective study
por: Tsukaguchi, Ryo, et al.
Publicado: (2022) -
Oral disintegrating desmopressin tablet is effective for partial congenital
nephrogenic diabetes insipidus with AVPR2 mutation: a case
report
por: Ikegawa, Kento, et al.
Publicado: (2022) -
SAT-416 Novel Autoantibodies for Thyroid-Specific Transcriptional Factors in Patients with Immune-Related Adverse Events Involving the Thyroid Gland
por: Yamauchi, Ichiro, et al.
Publicado: (2020) -
Formulation Design of Fast Disintegrating Tablets Using Disintegrant Blends
por: Shirsand, S. B., et al.
Publicado: (2010)